Bloomberg Technology

Biotech’s Race for Drug Development

Jul.07 — Nautilus Biotechnology Founder and CEO Sujal Patel discusses how his biotech startup company is developing a platform to measure and scan proteins in order to help accelerate drug development. He speaks with Emily Chang on “Bloomberg Technology.”

Published

3 years ago

on

Jul.07 — Nautilus Biotechnology Founder and CEO Sujal Patel discusses how his biotech startup company is developing a platform to measure and scan proteins in order to help accelerate drug development. He speaks with Emily Chang on “Bloomberg Technology.”

Related Topics:

2 Comments

  1. fatiha mebarki

    July 8, 2021 at 12:07 am

    السلام عليكم ورحمة الله وبركاته

    Reply

    • Metacognition88

      July 8, 2021 at 2:51 am

      😂

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version